Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Aug, 2018 | Pages:
100 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)
This report focuses on the global Metabolic Syndrome status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Metabolic Syndrome development in United States, Europe and China.
Metabolic syndrome is a cluster of conditions - increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels - that occur together, increasing your risk of heart disease, stroke and diabetes.
One of the upcoming trends gaining traction in the market is the increasing focus on oral insulin therapies. Till now, insulin injections were mostly administered through subcutaneous tissues, but this route of application is associated with risk of infection and hypersensitivity reactions, emboli, high cost, and injection site pain. Also, several needle-phobic individuals hesitate to adopt this route of administration. This paved the way for extensive research in the development of oral insulin. The oral form of insulin prevents the unpleasantness of insulin injections and other complications associated with the existing therapies. Moreover, oral administration of insulin ensures increased patient comfort and compliance, reduced risk of infection, simpler application, and is cost-effective.
In 2017, the global Metabolic Syndrome market size was 24600 million US$ and it is expected to reach 36700 million US$ by the end of 2025, with a CAGR of 5.1% during 2018-2025.
The key players covered in this study
Novo Nordisk
Sanofi
Merck
AstraZeneca
Eli Lily
AbbVie
Actelion Pharmaceuticals
Adocia
Aegerion Pharmaceuticals
Akros Pharma
Alnylam Pharmaceuticals
Amarin
nAmgen
Amicus Therapeutics
Arbutus Biopharma
Market segment by Type, the product can be split into
Diabetes
Obesity
Hypercholesterolemia
Lysosomal storage diseases
Market segment by Application, split into
Hospital
Clinic
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Metabolic Syndrome status, future forecast, growth opportunity, key market and key players.
To present the Metabolic Syndrome development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Metabolic Syndrome are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Metabolic Syndrome Market Size Growth Rate by Type (2013-2025)
1.4.2 Diabetes
1.4.3 Obesity
1.4.4 Hypercholesterolemia
1.4.5 Lysosomal storage diseases
1.5 Market by Application
1.5.1 Global Metabolic Syndrome Market Share by Application (2013-2025)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Metabolic Syndrome Market Size
2.2 Metabolic Syndrome Growth Trends by Regions
2.2.1 Metabolic Syndrome Market Size by Regions (2013-2025)
2.2.2 Metabolic Syndrome Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Metabolic Syndrome Market Size by Manufacturers
3.1.1 Global Metabolic Syndrome Revenue by Manufacturers (2013-2018)
3.1.2 Global Metabolic Syndrome Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Metabolic Syndrome Market Concentration Ratio (CR5 and HHI)
3.2 Metabolic Syndrome Key Players Head office and Area Served
3.3 Key Players Metabolic Syndrome Product/Solution/Service
3.4 Date of Enter into Metabolic Syndrome Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Metabolic Syndrome Market Size by Type (2013-2018)
4.2 Global Metabolic Syndrome Market Size by Application (2013-2018)
5 United States
5.1 United States Metabolic Syndrome Market Size (2013-2018)
5.2 Metabolic Syndrome Key Players in United States
5.3 United States Metabolic Syndrome Market Size by Type
5.4 United States Metabolic Syndrome Market Size by Application
6 Europe
6.1 Europe Metabolic Syndrome Market Size (2013-2018)
6.2 Metabolic Syndrome Key Players in Europe
6.3 Europe Metabolic Syndrome Market Size by Type
6.4 Europe Metabolic Syndrome Market Size by Application
7 China
7.1 China Metabolic Syndrome Market Size (2013-2018)
7.2 Metabolic Syndrome Key Players in China
7.3 China Metabolic Syndrome Market Size by Type
7.4 China Metabolic Syndrome Market Size by Application
8 Japan
8.1 Japan Metabolic Syndrome Market Size (2013-2018)
8.2 Metabolic Syndrome Key Players in Japan
8.3 Japan Metabolic Syndrome Market Size by Type
8.4 Japan Metabolic Syndrome Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Metabolic Syndrome Market Size (2013-2018)
9.2 Metabolic Syndrome Key Players in Southeast Asia
9.3 Southeast Asia Metabolic Syndrome Market Size by Type
9.4 Southeast Asia Metabolic Syndrome Market Size by Application
10 India
10.1 India Metabolic Syndrome Market Size (2013-2018)
10.2 Metabolic Syndrome Key Players in India
10.3 India Metabolic Syndrome Market Size by Type
10.4 India Metabolic Syndrome Market Size by Application
11 Central & South America
11.1 Central & South America Metabolic Syndrome Market Size (2013-2018)
11.2 Metabolic Syndrome Key Players in Central & South America
11.3 Central & South America Metabolic Syndrome Market Size by Type
11.4 Central & South America Metabolic Syndrome Market Size by Application
12 International Players Profiles
12.1 Novo Nordisk
12.1.1 Novo Nordisk Company Details
12.1.2 Company Description and Business Overview
12.1.3 Metabolic Syndrome Introduction
12.1.4 Novo Nordisk Revenue in Metabolic Syndrome Business (2013-2018)
12.1.5 Novo Nordisk Recent Development
12.2 Sanofi
12.2.1 Sanofi Company Details
12.2.2 Company Description and Business Overview
12.2.3 Metabolic Syndrome Introduction
12.2.4 Sanofi Revenue in Metabolic Syndrome Business (2013-2018)
12.2.5 Sanofi Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Metabolic Syndrome Introduction
12.3.4 Merck Revenue in Metabolic Syndrome Business (2013-2018)
12.3.5 Merck Recent Development
12.4 AstraZeneca
12.4.1 AstraZeneca Company Details
12.4.2 Company Description and Business Overview
12.4.3 Metabolic Syndrome Introduction
12.4.4 AstraZeneca Revenue in Metabolic Syndrome Business (2013-2018)
12.4.5 AstraZeneca Recent Development
12.5 Eli Lily
12.5.1 Eli Lily Company Details
12.5.2 Company Description and Business Overview
12.5.3 Metabolic Syndrome Introduction
12.5.4 Eli Lily Revenue in Metabolic Syndrome Business (2013-2018)
12.5.5 Eli Lily Recent Development
12.6 AbbVie
12.6.1 AbbVie Company Details
12.6.2 Company Description and Business Overview
12.6.3 Metabolic Syndrome Introduction
12.6.4 AbbVie Revenue in Metabolic Syndrome Business (2013-2018)
12.6.5 AbbVie Recent Development
12.7 Actelion Pharmaceuticals
12.7.1 Actelion Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Metabolic Syndrome Introduction
12.7.4 Actelion Pharmaceuticals Revenue in Metabolic Syndrome Business (2013-2018)
12.7.5 Actelion Pharmaceuticals Recent Development
12.8 Adocia
12.8.1 Adocia Company Details
12.8.2 Company Description and Business Overview
12.8.3 Metabolic Syndrome Introduction
12.8.4 Adocia Revenue in Metabolic Syndrome Business (2013-2018)
12.8.5 Adocia Recent Development
12.9 Aegerion Pharmaceuticals
12.9.1 Aegerion Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Metabolic Syndrome Introduction
12.9.4 Aegerion Pharmaceuticals Revenue in Metabolic Syndrome Business (2013-2018)
12.9.5 Aegerion Pharmaceuticals Recent Development
12.10 Akros Pharma
12.10.1 Akros Pharma Company Details
12.10.2 Company Description and Business Overview
12.10.3 Metabolic Syndrome Introduction
12.10.4 Akros Pharma Revenue in Metabolic Syndrome Business (2013-2018)
12.10.5 Akros Pharma Recent Development
12.11 Alnylam Pharmaceuticals
12.12 Amarin
12.13 nAmgen
12.14 Amicus Therapeutics
12.15 Arbutus Biopharma
13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Metabolic Syndrome Key Market Segments
Table Key Players Metabolic Syndrome Covered
Table Global Metabolic Syndrome Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Metabolic Syndrome Market Size Market Share by Type 2013-2025
Figure Diabetes Figures
Table Key Players of Diabetes
Figure Obesity Figures
Table Key Players of Obesity
Figure Hypercholesterolemia Figures
Table Key Players of Hypercholesterolemia
Figure Lysosomal storage diseases Figures
Table Key Players of Lysosomal storage diseases
Table Global Metabolic Syndrome Market Size Growth by Application 2013-2025 (Million US$)
Figure Hospital Case Studies
Figure Clinic Case Studies
Figure Others Case Studies
Figure Metabolic Syndrome Report Years Considered
Table Global Metabolic Syndrome Market Size 2013-2025 (Million US$)
Figure Global Metabolic Syndrome Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Metabolic Syndrome Market Size by Regions 2013-2025 (Million US$)
Table Global Metabolic Syndrome Market Size by Regions 2013-2018 (Million US$)
Table Global Metabolic Syndrome Market Share by Regions 2013-2018
Figure Global Metabolic Syndrome Market Share by Regions 2013-2018
Figure Global Metabolic Syndrome Market Share by Regions 2018
Table Market Top Trends
Table Global Metabolic Syndrome Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Metabolic Syndrome Market Share by Manufacturers (2013-2018)
Figure Global Metabolic Syndrome Market Share by Manufacturers in 2018
Table Global Metabolic Syndrome Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Metabolic Syndrome Product/Solution/Service
Table Date of Enter into Metabolic Syndrome Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Metabolic Syndrome Market Size by Type (2013-2018) (Million US$)
Table Global Metabolic Syndrome Market Size Share by Type (2013-2018)
Figure Global Metabolic Syndrome Market Size Market Share by Type (2013-2018)
Table Global Metabolic Syndrome Market Size by Application (2013-2018) (Million US$)
Table Global Metabolic Syndrome Market Size Share by Application (2013-2018)
Figure Global Metabolic Syndrome Market Size Market Share by Application (2013-2018)
Figure Global Metabolic Syndrome Revenue Market Share by Application in 2017
Figure United States Metabolic Syndrome Market Size 2013-2018 (Million US$)
Table United States Key Players Metabolic Syndrome Revenue (2017-2018) (Million US$)
Table United States Key Players Metabolic Syndrome Market Share (2017-2018)
Table United States Metabolic Syndrome Market Size by Type (2013-2018) (Million US$)
Table United States Metabolic Syndrome Market Share by Type (2013-2018)
Table United States Metabolic Syndrome Market Size by Application (2013-2018) (Million US$)
Table United States Metabolic Syndrome Market Share by Application (2013-2018)
Figure Europe Metabolic Syndrome Market Size 2013-2018 (Million US$)
Table Europe Key Players Metabolic Syndrome Revenue (2017-2018) (Million US$)
Table Europe Key Players Metabolic Syndrome Market Share (2017-2018)
Table Europe Metabolic Syndrome Market Size by Type (2013-2018) (Million US$)
Table Europe Metabolic Syndrome Market Share by Type (2013-2018)
Table Europe Metabolic Syndrome Market Size by Application (2013-2018) (Million US$)
Table Europe Metabolic Syndrome Market Share by Application (2013-2018)
Figure China Metabolic Syndrome Market Size 2013-2018 (Million US$)
Table China Key Players Metabolic Syndrome Revenue (2017-2018) (Million US$)
Table China Key Players Metabolic Syndrome Market Share (2017-2018)
Table China Metabolic Syndrome Market Size by Type (2013-2018) (Million US$)
Table China Metabolic Syndrome Market Share by Type (2013-2018)
Table China Metabolic Syndrome Market Size by Application (2013-2018) (Million US$)
Table China Metabolic Syndrome Market Share by Application (2013-2018)
Figure Japan Metabolic Syndrome Market Size 2013-2018 (Million US$)
Table Japan Key Players Metabolic Syndrome Revenue (2017-2018) (Million US$)
Table Japan Key Players Metabolic Syndrome Market Share (2017-2018)
Table Japan Metabolic Syndrome Market Size by Type (2013-2018) (Million US$)
Table Japan Metabolic Syndrome Market Share by Type (2013-2018)
Table Japan Metabolic Syndrome Market Size by Application (2013-2018) (Million US$)
Table Japan Metabolic Syndrome Market Share by Application (2013-2018)
Figure Southeast Asia Metabolic Syndrome Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Metabolic Syndrome Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Metabolic Syndrome Market Share (2017-2018)
Table Southeast Asia Metabolic Syndrome Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Metabolic Syndrome Market Share by Type (2013-2018)
Table Southeast Asia Metabolic Syndrome Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Metabolic Syndrome Market Share by Application (2013-2018)
Figure India Metabolic Syndrome Market Size 2013-2018 (Million US$)
Table India Key Players Metabolic Syndrome Revenue (2017-2018) (Million US$)
Table India Key Players Metabolic Syndrome Market Share (2017-2018)
Table India Metabolic Syndrome Market Size by Type (2013-2018) (Million US$)
Table India Metabolic Syndrome Market Share by Type (2013-2018)
Table India Metabolic Syndrome Market Size by Application (2013-2018) (Million US$)
Table India Metabolic Syndrome Market Share by Application (2013-2018)
Figure Central & South America Metabolic Syndrome Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Metabolic Syndrome Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Metabolic Syndrome Market Share (2017-2018)
Table Central & South America Metabolic Syndrome Market Size by Type (2013-2018) (Million US$)
Table Central & South America Metabolic Syndrome Market Share by Type (2013-2018)
Table Central & South America Metabolic Syndrome Market Size by Application (2013-2018) (Million US$)
Table Central & South America Metabolic Syndrome Market Share by Application (2013-2018)
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Metabolic Syndrome Business (2013-2018) (Million US$)
Figure Novo Nordisk Revenue Growth Rate in Metabolic Syndrome Business (2013-2018)
Table Novo Nordisk Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Metabolic Syndrome Business (2013-2018)(Million US$)
Figure Sanofi Revenue Growth Rate in Metabolic Syndrome Business (2013-2018)
Table Sanofi Recent Development
Table Merck Company Details
Table Merck Revenue in Metabolic Syndrome Business (2013-2018)(Million US$)
Figure Merck Revenue Growth Rate in Metabolic Syndrome Business (2013-2018)
Table Merck Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Metabolic Syndrome Business (2013-2018)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Metabolic Syndrome Business (2013-2018)
Table AstraZeneca Recent Development
Table Eli Lily Company Details
Table Eli Lily Revenue in Metabolic Syndrome Business (2013-2018)(Million US$)
Figure Eli Lily Revenue Growth Rate in Metabolic Syndrome Business (2013-2018)
Table Eli Lily Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Metabolic Syndrome Business (2013-2018)(Million US$)
Figure AbbVie Revenue Growth Rate in Metabolic Syndrome Business (2013-2018)
Table AbbVie Recent Development
Table Actelion Pharmaceuticals Company Details
Table Actelion Pharmaceuticals Revenue in Metabolic Syndrome Business (2013-2018)(Million US$)
Figure Actelion Pharmaceuticals Revenue Growth Rate in Metabolic Syndrome Business (2013-2018)
Table Actelion Pharmaceuticals Recent Development
Table Adocia Company Details
Table Adocia Revenue in Metabolic Syndrome Business (2013-2018)(Million US$)
Figure Adocia Revenue Growth Rate in Metabolic Syndrome Business (2013-2018)
Table Adocia Recent Development
Table Aegerion Pharmaceuticals Company Details
Table Aegerion Pharmaceuticals Revenue in Metabolic Syndrome Business (2013-2018)(Million US$)
Figure Aegerion Pharmaceuticals Revenue Growth Rate in Metabolic Syndrome Business (2013-2018)
Table Aegerion Pharmaceuticals Recent Development
Table Akros Pharma Company Details
Table Akros Pharma Revenue in Metabolic Syndrome Business (2013-2018)(Million US$)
Figure Akros Pharma Revenue Growth Rate in Metabolic Syndrome Business (2013-2018)
Table Akros Pharma Recent Development
Table Alnylam Pharmaceuticals Company Details
Table Amarin Company Details
Table nAmgen Company Details
Table Amicus Therapeutics Company Details
Table Arbutus Biopharma Company Details
Table Global Metabolic Syndrome Market Size by Regions (Million US$) 2018-2025
Figure Global Metabolic Syndrome Market Size Share by Regions (2018-2025)
Figure Global Metabolic Syndrome Market Size Share by Regions in 2025
Figure United States Metabolic Syndrome Market Size Forecast (2018-2025)(Million USD)
Figure Europe Metabolic Syndrome Market Size Forecast (2018-2025)(Million USD)
Figure China Metabolic Syndrome Market Size Forecast (2018-2025)(Million USD)
Figure Japan Metabolic Syndrome Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Metabolic Syndrome Market Size Forecast (2018-2025)(Million USD)
Figure India Metabolic Syndrome Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Metabolic Syndrome Market Size Forecast (2018-2025)(Million USD)
Table Global Metabolic Syndrome Market Size by Product (2018-2025) (Million US$)
Figure Global Metabolic Syndrome Market Size by Product (2018-2025)
Figure Global Metabolic Syndrome Market Size by Product in 2025
Table Global Metabolic Syndrome Market Size by Application (2018-2025) (Million US$)
Figure Global Metabolic Syndrome Market Size by Application (2018-2025)
Figure Global Metabolic Syndrome Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
